If we see success at the trial and get to commercialization, we will see revenues of $2b+. While considering the revenue and future IP we have developed for other indicators, it is not hard to see the company getting bought out at the $3-5 range. If you believe in the science, it is a matter of when and not if. If you don't believe in the science, than this isn't the stock for you.
If we see success at the trial and get to commercialization, we...
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
